What is MDT's health score?

Medtronic plc (MDT) has a TradeApes health score of 67 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is MDT's estimated fair value?

Based on our 5-year discounted cash flow model, Medtronic plc's estimated fair value is $65.92 per share, representing a -19.3% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is MDT undervalued or overvalued?

Our model currently rates MDT as Fair Value. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for MDT... Refresh in a moment for the full analysis.

Medtronic plc (MDT)

Healthcare Fair Value low healthy

$81.67

Updated: 2026-06-06

TradeApes Score

Financial Strength

80 Strong

Operating Trend

58 Mixed

Relative Value

63 Healthy

Capital Allocation

55 Mixed

Risk

80 Strong

Est. Fair Value $65.92

DCF Upside -19.3%

Sector Rank #5799 of 6646

Key Findings

+ Net cash position — more cash on hand than total debt

Unlock Full Report →

− Piotroski F-Score 0–3 — multiple financial weakness signals

Unlock Full Report →

3 free score cards remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.